|
1,25(OH)2D3对宫颈癌作用的研究进展
|
Abstract:
[1] | 王丽萍, 黄金. 维生素D与肥胖关系的研究进展[J]. 中国全科医学, 2014, 17(14): 1581-1583. |
[2] | 蒋普, 蒋迎九. 1,25二羟基维生素D3对肺癌的抑制作用[J]. 检验医学与临床, 2013, 10(8): 998-1000. |
[3] | Ray, R. and Lambert, J.R. (2011) 1α,25-Dihydroxyvitamin D3-3β-Bromoacetate, a Potential Cancer Therapeutic Agent: Synthesis and Molecular Mechanism of Action. Bioorganic & Medicinal Chemistry Letters, 21, 2537-2540.
http://dx.doi.org/10.1016/j.bmcl.2011.02.025 |
[4] | 崔健, 陈虹, 黄秉仁. 维生素D受体最新研究进展[J]. 生理科学进展, 2011, 42(2): 95-99. |
[5] | Holick, M.F. (2004) Vitamin D: Importance in the Prevention of Cancers, Type 1 Diabetes, Heart Disease, and Osteoporosis. American Journal of Clinical Nutrition, 79, 362-371. http://dx.doi.org/10.1016/j.bmcl.2011.02.025 |
[6] | Demay, M.B. (2006) Mechanism of Vitamin D Receptor Action. Annals of the New York Academy of Sciences, 1068, 204-213. http://dx.doi.org/10.1196/annals.1346.026 |
[7] | 马淑状. PTEN Ki-67 Bax蛋白与卵巢肿瘤关系的研究[D]: [硕士学位论文]. 太原: 山西医科大学, 2009. |
[8] | Prudencio, J., Akutsu, N., et al. (2001) Action of Low Calcemic 1,25-Dihydroxyvitamin D3 Analogue EBl089 in Head and Neck Head and Neck Squamous Cell Carcinoma. Journal of the National Cancer Institute, 93, 745-753.
http://dx.doi.org/10.1093/jnci/93.10.745 |
[9] | Beer, T.M. and Myrthue, A. (2004) Calcitriol in Cancer Treatment: From the Lab to the Clinic. Molecular Cancer Therapeutics, 3, 373-381. |
[10] | Eelen, G. (2007) Mechanism and Potential of the Growth-Inhibitory Actions of Vitamin D and Analogs. Current Medicinal Chemistry, 14, 1893-1910. http://dx.doi.org/10.2174/092986707781058823 |
[11] | Lu, H.Q. and Zheng, J. (2006) Synergistic Inhibitory Effect of All-Trans Retinoic Acid and l,25-Dihydroxy Vitamin D3 on Growth of Human Hepatoma Cell Line HepG2. Ai Zheng, 25, 1470-1476. |
[12] | Li, P., Li, C., Zhao, X., et al. (2004) p27(Kip1) Stabilization and G(1) Arrest by 1,25-Dihydroxyvitamin D(3) in Ovarian Cancer Cells Mediated through Down-Regulation of Cyclin E/Cyclin-Dependent Kinase 2 and Skp1-Cullin-F-Box Pro-tein/Skp2 Ubiquitin Ligase. Journal of Biological Chemistry, 279, 25260-25267.
http://dx.doi.org/10.1074/jbc.M311052200 |
[13] | Hughes, P.J., Lee, J.S., Reiner, N.E., et al. (2008) The Vitamin D Recep-tor-Mediated Activation of Phosphatidylinositol 3-Kinase (PI3Kalpha) Plays a Role in the 1alpha,25-Dihydroxyvitamin D3-Stimulated Increase in Steroid Sulphatase Activity in Myeloid Leukaemic Cell Lines. Journal of Cellular Biochemistry, 103, 1551-1572.
http://dx.doi.org/10.1002/jcb.21545 |
[14] | 胡志勇, 周逸鹏, 黎书炜, 等. 1,25-二羟基维生素D3增强卡铂对人肺癌A549细胞的杀伤效果[J]. 肿瘤防治研究, 2013, 40(2): 125-130. |
[15] | Pacher, P. and Hajnóczky, G. (2001) Propagation of the Apoptotic Signal by Mitochondrial Waves. EMBO Journal, 20, 4107-4121. http://dx.doi.org/10.1093/emboj/20.15.4107 |
[16] | Blutt, S.E., McDonnell, T.J., Polek, T.C. and Weigel, N.L. (2000) Calcitriol Induced Apoptosis in LNCaP Cells Is Blocked by Overexpression of Bcl-2. Endocrinology, 141, 10-17. |
[17] | Verlinden, L., Verstuyf, A., VanCamp, M., et al. (2000) Two Novel 14-Epianalogues of 1,25-Dihydroxyvitamin D3 Inhibit the Growth of Human Breast Cancer Cells in Vitro and in Vivo. Cancer Research, 60, 2673-2679. |
[18] | Pirianov, G. and Cilston, K.W. (2001) Interaction of Vitamin D Analogs with Signing Path Way Leading to Active Cell Death in Breast Cancer Cell. Steroids, 66, 309-318. http://dx.doi.org/10.1016/S0039-128X(00)00201-4 |
[19] | 段娥. 维生素D及其受体与妇科肿瘤[J]. 国外医学妇产科学杂志, 2005, 32(4): 213-216. |
[20] | Koli, K. and Keski, O.J. (2000) 1 Alpha,25-Dihydroxy Vitamin D3 and Its Analogues down Regulate Cell Invasion-Associated Protease in Cult Ured Malignant Cells. Cell Growth & Differentiation, 11, 221-229. |
[21] | Ben-Shoshan, M., Amir, S., Dang, D.T., et al. (2007) 1 Alpha,25-Dihydroxyvitamin D3(Calcitriol)Inhibits Hypoxia-Inducible Factor-1/Vascular Endothelial Growth Factor Pathway in Human Cancer Cells. Molecular Cancer Therapeutics, 6, 1433-1439. http://dx.doi.org/10.1158/1535-7163.MCT-06-0677 |
[22] | Bemd, G.J. and Chang, G.T. (2002) Vitamin D and Vitamin D Analogs Cancer Treatment. Curt Drug Targets, 3, 85- 94. http://dx.doi.org/10.2174/1389450023348064 |
[23] | Kumagai, T., O’Kelly, J., Said, J.W., et al. (2003) Vitamin D3 Analog 19-Nor-1,25-Dihydroxyvitamin D2: Antitumor Activity against Leukemia, Myeloma, Andcolon Cancer Cells. National Cancer Institute, 95, 896-905.
http://dx.doi.org/10.1093/jnci/95.12.896 |
[24] | Molnar, I., Kute, T., Willingham, M.C., et al. (2003) 19-Nor-1 Alpha,25 Dihydroxyvitamin D2(Paricalcitol): Effects on Clonal Proliferation, Differentiation, and Apoptosis in Human Leukemic Cells. Cancer Research and Clinical Oncology, 129, 35-42. |
[25] | Light, B.W., Yu, W.D. and Mariann, C. (1997) Potentiation of Cisplatin Antitumor Activity Using a Vitamin D Analogue in a Murine Squamous Cell Carcinoma Model System. Cancer Research, 57, 3759-3764. |
[26] | Reichrath, J., Rafi, L., Muller, S.M., et al. (1998) Immunohistochernical Analysis of 1,25-Dihydroxyvitamin D3 Receptorin Cervical Carcinoma. Histochern, 30, 561-567. http://dx.doi.org/10.1023/A:1003283117492 |
[27] | 侯萍, 张燕, 高伟, 姜常青. 维生素D受体在宫颈癌中的表达及临床意义[J]. 中国煤炭工业医学杂志, 2009, 12(5): 694-696. |
[28] | 张凤, 邢丽娜, 马艳伟, 等. 1,25-二羟基维生素D3对鼠宫颈癌免疫作用的研究[J]. 哈尔滨医科大学学报, 2015, 49(1): 30-33. |
[29] | 于君丽, 刁尧, 郭科军, 等. 钙与维生素D3抑制人宫颈癌细胞和组织增殖作用的相关性研究[J]. 中国医科大学学报, 2005, 34(5): 403-405. |
[30] | 林兰, 林锦贤, 余江, 林善英. 人宫颈癌SiHa细胞核维生素D受体的检测[J]. 福建医药杂志, 2012, 34(4): 73-75. |
[31] | 蔡叶樨, 张红河, 倪慧群, 徐庆嵩. 血浆Th17细胞相关因子与25-羟基维生素D检测对宫颈癌的临床价值[J]. 全科医学临床与教育, 2014, 12(3): 263-265. |
[32] | 应倩, 夏庆民, 郑荣寿, 张思维, 陈万青. 中国2009年宫颈癌发病与死亡分析[J]. 中国肿瘤, 2013, 22(8): 612- 616. |
[33] | 石远凯, 孙燕. 临床肿瘤内科手册[M]. 第6版. 北京: 人民卫生出版社, 2015. |
[34] | 陈秀慧, 曲军英. 不同质量浓度顺铂对宫颈癌Hela细胞增殖能力的影响[J]. 中国临床药理学杂志, 2014, 30(7): 601-602. |
[35] | Wang, T.H., Wang, J.Y., Gong, X., Li, H.Z. and Cheng, Y. (2012) Tetrandrine Enhances Cytotoxicity of Cisplatin in Human Drug-Resistant Esophageal Squamous Carcinoma Cells by Inhibition of Multidrug Resistance-Associated Protein l. Oncology Reports, 5, 1681-1686. |